Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma Therapy
New adenocarcinoma therapy study results from National Cancer Center Hospital described
March 30th, 2008
Fresh data on adenocarcinoma are presented in the report 'Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.' "Surgery is the standard treatment for neoplasms located at the esophagogastric junction (EGJ), and, recently, EMR, photodynamic therapy (PDT), or both have also been used for early stage neoplasms located at the EGJ. Endoscopic submucosal dissection (ESD) is a newly developed technique in the field of endoscopic treatments for GI neoplasms because of its high rate of en bloc resection," researchers in Tokyo, Japan report. "We used ESD for superficial adenocarcinoma located at the EGJ and...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-30)
|
